INIS
metabolites
100%
concentration
100%
enzymes
100%
caffeine
100%
adp
100%
polymerases
100%
ribose
100%
inflammation
42%
diseases
28%
production
28%
hydrogen
28%
nad
28%
levels
14%
doses
14%
lungs
14%
humans
14%
demand
14%
pathology
14%
dna
14%
mitochondria
14%
inhibition
14%
cytokines
14%
evaluation
14%
injuries
14%
ischemia
14%
capacity
14%
substrates
14%
xanthines
14%
atp
14%
polymers
14%
necrosis
14%
antioxidants
14%
elisa
14%
theophylline
14%
strand breaks
14%
theobromine
14%
3,7-dimethylxanthine
14%
Keyphrases
Physiological Concentrations
100%
PARP Inhibitor (PARPi)
100%
Caffeine Metabolites
100%
1,7-dimethylxanthine
40%
Methylxanthines
30%
Inhibiting Activity
30%
Caffeine
20%
Chronic Inflammatory Diseases
20%
Hydrogen Peroxide
20%
High Dose
10%
Vascular Complications
10%
Inflammatory Cytokines
10%
Pathophysiology
10%
Diabetes
10%
Nutritional Intervention
10%
Epithelial Cells
10%
Nuclear factor-κB
10%
Necrosis
10%
Ischemia-reperfusion Injury
10%
Endothelial Cells
10%
Activator protein-1 (AP-1)
10%
Vascular Endothelial Cells
10%
Theophylline
10%
DNA Double-strand Breaks
10%
Acute Inflammatory Diseases
10%
ELISA Assay
10%
Acute Inflammatory
10%
Inflammatory Pathologies
10%
A549
10%
Theobromine
10%
Lung Epithelial
10%
Antioxidant Effect
10%
Mitochondrial ATP Production
10%
Poly(ADP-ribose) Polymers
10%
Overactivation
10%
3-methylxanthine
10%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Paraxanthine
100%
Methylxanthine
50%
Disease
25%
Enzyme-Linked Immunosorbent Assay
25%
Pathophysiology
25%
Antioxidant
25%
Adenosine Triphosphate
25%
Cytokine
25%
Reperfusion Injury
25%
Inflammatory Disease
25%
Necrosis
25%
Theophylline
25%
Poly(adenosine Diphosphate Ribose)
25%
1 Methylxanthine
25%
3 Methylxanthine
25%
Theobromine
25%